First Trust Advisors Reduces McKesson Stake

Institutional investor sells 4,705 shares of pharmaceutical distributor

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

First Trust Advisors LP, an institutional investor, has reduced its position in McKesson Corporation (NYSE:MCK) by selling 4,705 shares in the third quarter. The firm now owns 166,050 shares, or about 0.13% of the company's stock, worth $128,280,000 as of its most recent SEC filing.

Why it matters

The sale by First Trust Advisors, while relatively small, reflects ongoing changes in institutional ownership of McKesson shares. As a major pharmaceutical distributor, McKesson's stock performance and ownership structure are closely watched by investors.

The details

According to the SEC filing, First Trust Advisors sold 4,705 shares of McKesson, reducing its total position to 166,050 shares. The firm now owns about 0.13% of the company's outstanding stock. McKesson's shares have traded in a 52-week range of $633.53 to $999.00, closing most recently at $918.37.

  • First Trust Advisors made the share sale in the third quarter of the most recent fiscal year.

The players

First Trust Advisors LP

An institutional investor and asset management firm.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in First Trust Advisors' McKesson stake, while small, reflects the ongoing shifts in institutional ownership of the pharmaceutical distributor's shares. As a major player in the healthcare supply chain, McKesson's stock performance and shareholder composition remain closely watched by investors.